GLP-1 Receptor Agonists Show Promise in Addiction Treatment, But Experts Urge Caution
Key Insights
GLP-1 receptor agonists (search), already revolutionizing weight-loss and diabetes treatment, are now being investigated for potential applications in addiction (search) treatment.
Dr. Dhruv Khullar, a physician at Weill Cornell Medical College, expresses optimism about GLP-1s for addiction (search) but cautions against labeling them a "miracle drug."
The TED Radio Hour episode explores whether medication alone can adequately treat a disease as complex as addiction (search), featuring perspectives from multiple experts.
GLP-1 receptor agonists (search), the class of medications that has already transformed the landscape of weight-loss and diabetes treatment, may hold new promise for one of medicine's most intractable challenges: addiction (search). Yet leading voices in the field are urging measured expectations, emphasizing that pharmacology alone may not be sufficient to address such a complex disease.
Dr. Dhruv Khullar, a physician and associate professor of health policy and economics at Weill Cornell Medical College, is among those cautiously optimistic about the potential of GLP-1s in addiction (search) treatment. Speaking as part of the TED Radio Hour episode "Rethinking addiction in the age of Ozempic," Khullar acknowledged the groundbreaking nature of these medications while resisting the temptation to frame them as a panacea.
"GLP-1s revolutionized weight-loss and diabetes treatment. Could addiction (search) be next?" the episode poses. "Dr. Dhruv Khullar is optimistic, but he's cautious about calling them a miracle drug for treating addiction."
The discussion, which aired on NPR, brought together multiple perspectives on the intersection of modern pharmacology and addiction (search) science. Alongside Khullar, the program featured author and behavioral coach Eric Zimmer and journalist Nayeema Raza, reflecting a deliberate effort to balance biomedical innovation with behavioral and societal dimensions of addiction.
A Disease Demanding More Than Medication
Central to the episode is a question that resonates across the addiction (search) medicine community: Is medicine alone enough to treat such a complicated disease? The framing of addiction as a disease—a concept Khullar has explored in his academic work and a related TED Talk titled "Addiction is a disease. We should treat it like one"—provides the scientific foundation for investigating pharmacological interventions. Yet the episode's structure suggests that even the most promising medications must be integrated into a broader therapeutic framework.
Khullar's academic research, published in leading journals including JAMA and The New England Journal of Medicine, lends weight to his measured assessment. His dual role as a clinician and a contributor to The New Yorker positions him at the nexus of scientific rigor and public understanding, making his cautionary notes particularly salient.
The Broader Conversation
The TED Radio Hour episode situates the GLP-1–addiction (search) conversation within a larger cultural and scientific reexamination of how society understands and treats substance use disorders. By featuring voices from medicine, behavioral coaching, and journalism, the program underscores the multidimensional nature of addiction—a condition shaped by neurobiology, psychology, social determinants, and individual behavior.
As research into GLP-1s and addiction (search) progresses, the episode serves as both a marker of scientific momentum and a reminder that breakthrough pharmacology, however transformative, operates within the complex reality of human lives.